Bradway Robert A

Chairman, CEO and President, Director

Avg. Two Year Performance

32% Avg. Purchase Return    15% Compound
(12%) Avg. Sale Return    (6%) Compound

Holdings: 641.73K shares

Last Three Months: 25-Nov-23 -- 24-Feb-24

0 Net Amount
Buy:0--
Sell:0--

Sentiment

Insider Trading Sentiment: Hold

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment:
Insider Trading Sentiment:
Insider Trading Sentiment:

Two Year Chart

25-Feb-22 -- 24-Feb-24

Price ($)

Sentiment

Company Sentiment

Most Recent Insider Transactions